FDA approves fewer Indian copycat drugs (Indian Express via Yahoo! India News)
The number of approved abbreviated new drug applications (ANDAs) filed by Indian pharmaceutical companies-which have aggressively launched copycat versions of off-patent drugs in the US market-has declined dramatically in the last four months. Generic companies file ANDAs to obtain marketing approvals for drugs whose patents expire in the United States, the world's largest pharma market. Last ...

Angiotech Receives CE Mark Approval of Quill(TM) SRS MONODERM(TM), a New Rapidly Resorbing Suture Product Line (FinanzNachrichten)
VANCOUVER, Oct. 11 /PRNewswire-FirstCall/ -- Angiotech Pharmaceuticals, ( Nachrichten ) Inc. , a global specialty pharmaceutical and medical device company, today announced that it has received CE Mark approval to begin marketing the Quill(TM) Self-Retaining System (SRS) MONODERM(TM) sutures in Europe.